As we explored in our previous blog post, Advocacy groups have increasingly been collaborating with the pharmaceutical industry over a wide range of areas, and we expect to see the number and impact of these collaborations to grow over the next few years. One of the major areas of this growth will be in advocacy… Continue reading Working with Advocacy to Address DEI: A Trend Worth Keeping

From where we are sitting, we have a really fortunate vantage point to observe the continued growth of the role of Advocacy groups in clinical research. To us, the past 12 months have been quite exciting in this regard. We’ve seen more and more Pharma partners find new and impactful ways to collaborate with Advocacy,… Continue reading Momentum to Define the Role of Advocacy Groups in Research is Growing – But Why?